Mandate

Vinge has advised the Swedish state in connection with its sale of shares in SAS

October 13, 2016

Vinge has advised the Swedish state in connection with its sale of shares in SAS pursuant to a bookbuilding procedure performed on 12 October 2016.

In total, 23 million ordinary shares held by the Swedish and Norwegian governments were placed at a price of SEK 15.50 per share, equivalent to an aggregate value of approximately MSEK 357.  Following the transaction, the Swedish government holds 17.2 per cent of the ordinary shares and 17.1 per of the votes in SAS.

Vinge’s team consisted of partners Charlotte Levin and Eric Sjöman together with associates Amanda Knutsson and David Andersson.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024